Nike Inc. (NYSE:NKE) stands on a powerful balance sheet featuring $8.4 billion in cash and short-term investments, a net cash position, and gross margins of 42.8%, providing substantial liquidity to navigate macroeconomic cycles. However, as the brand faces an operational pivot between shrinking lifestyle revenues and accelerating performance categories, questions mount over whether Nike is losing its edge in sportswear against rising competitors like On, click here to find out.
While top-line growth is temporarily weighed down by deliberate inventory cutbacks and a high single-digit revenue decline guidance for the full year, Nike’s case centers on long-term compounding potential driven by strong pricing power in technical athletic gear, gross margin expansion, and a multi-year $2.5 billion restructuring cost-saving program designed to restore underlying operating leverage.
Nike reported that its first-quarter revenue slipped 5% on a currency-neutral basis to $11.2 billion on October 1, and management said the full year should decline by a high single-digit rate. But the quarter is really two businesses pulling in opposite directions. Sport-specific products are growing, lifestyle products are shrinking, and the share price has to decide which one matters more.
Performance Is Quietly Sprinting
The brightest spot is the performance portfolio, which grew high single digits and would have grown low double digits without the China reset. Running, global football, tennis and golf all posted double-digit gains. In running, Nike nearly tripled its share of the max cushioning category over the past year, largely thanks to the Vomero. Football gave a second proof point. World Cup team kit sales doubled versus the 2022 tournament, and club kits rose into the high teens, which matters because club fans keep buying season after season.
Meanwhile, the cost side is moving the right way. Gross margin improved 60 basis points to 42.8%, and SG&A fell 3% to $3.9 billion, so the company is trimming the cost base while it spends more on marketing around big sporting events. Management also unveiled Pace, a restructuring program that targets roughly $2.5 billion in savings for about $1 billion in costs, with most of the benefit arriving in fiscal 2029 and 2030. The balance sheet gives Nike room to wait, with $8.4 billion in cash and short-term investments and a net cash position.
The Lifestyle Hangover Lingers
Performance simply isn’t big enough yet to cover the holes elsewhere. Sportswear makes up just under half of revenue and fell into the low double digits. Nike cut Dunk sales by nearly 50% on purpose, a hit of about $200 million, and some older, high-volume shoes sold through below expectations, which has already weakened future order books. Jordan Brand, at 13% of the business, fell by the mid-teens as management pulls back on retro releases to make them feel scarce again. Converse sank 28% to $263 million.
China is the other open wound. Revenue there dropped 26% to $1.18 billion as Nike prunes digital channels that were deeply discounting its products, and the CFO said the guidance assumes China gets worse from here. Nike Direct fell 9%, with its digital arm down 13%. Management expects operating profit to fall by more than revenue, and adjusted earnings per share of $1.15 to $1.35 for the year leave out about $0.15 of Pace costs. The company also warned these resets could spill into fiscal 2028.
What Wall Street Is Paying
Hedge fund interest cooled, with 56 funds holding Nike in the latest quarter versus 71 in the prior one. Short interest is 8.98% of the float, a real bear camp, though some of that is likely hedging rather than conviction. This elevated short interest reflects hedge fund skepticism over whether Nike can recover its lifestyle momentum before market share erodes further, alongside macro weakness in Greater China and near-term earnings friction from restructuring.
Then comes the valuation question everyone asks: is a forward P/E of 21.01 cheap? Not on the current run rate. Given that revenue and operating profit are both guided lower this fiscal year, a forward P/E of 21.01 indicates the stock is relatively expensive relative to its near-term earnings contraction. At this multiple, investors are not getting a discounted asset; rather, they are paying upfront for an anticipated multi-year earnings rebound. What if the rebound is late? Management points to fiscal 2029 and 2030 for the bulk of Pace savings, so the patience required spans years, not quarters. And does the cash cushion help? It does, and the roughly $610 million returned through dividends this quarter shows the payout is a priority, but neither changes the earnings base the multiple sits on. The next real catalyst is the November Investor Day, where management promised to detail its long-term growth plan.
Patience Has A Price
Nike’s price asks you to look through a messy year toward a healthier company, and the evidence backs that view only in part. The performance engine is real, and Pace offers a credible route to better margins. But the lifestyle and China resets are deliberate and slow, and management itself says they will weigh on results into the following year. Whether sport-led growth can outrun those cleanups is the bull’s whole case, while a longer-than-planned cleanup is the bear’s.
While we acknowledge the risk and potential of NKE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NKE and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: Top 10 AI Stocks That Will Skyrocket and 2 Stocks Trump Bought in July Are Now Down 17% to 20%. Time to Buy?
Hedge Fund Resource Center